AI/ML Innovations Inc. (CSE:AIML)
Canada · Delayed Price · Currency is CAD | Market Cap | 10.99M +3.9% |
| Revenue (ttm) | 83.06K -37.6% |
| Net Income | -6.36M |
| EPS | -0.03 |
| Shares Out | 274.67M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 108,830 |
| Open | 0.0400 |
| Previous Close | 0.0450 |
| Day's Range | 0.0400 - 0.0400 |
| 52-Week Range | 0.0300 - 0.0850 |
| Beta | 1.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 3, 2026 |
About AI/ML Innovations
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge’s solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and weara... [Read more]
Financial Performance
In fiscal year 2025, AI/ML Innovations's revenue was 167,307, a decrease of -72.12% compared to the previous year's 600,137. Losses were -4.59 million, 39.8% more than in 2024.
Financial StatementsNews
AI/ML Innovations Inc. Closes First Tranche of Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / August 26, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (...
AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield(TM) Pilot
Pilot to Evaluate MaxYield™ and CardioYield™ in Real-World Mobile Holter Monitoring Workflow on Southern Vancouver Island TORONTO, ON / ACCESS Newswire / August 18, 2026 / AI/ML Innovations Inc. ("AIM...
AI/ML Innovations Inc. Announces Proposed Private Placement
TORONTO, ON / ACCESS Newswire / August 14, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FSE:42FB) is pleased to announce that it is proposing to complete a non-broke...
AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
Quality Management System Certification Strengthens NeuralCloud's Regulatory Readiness for ECG Software-as-a-Medical-Device Platform TORONTO, ON / ACCESS Newswire / August 11, 2026 / AI/ML Innovations...
AI/ML Innovations Announces Completion of Share Issuance
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / July 2, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE...
AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis
Patent covers machine learning techniques for ECG denoising, rhythm classification, sample-level labelling, wearable cardiac monitoring, and report generation TORONTO, ON / ACCESS Newswire / June 23, ...
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
Appointments bring more than 50 combined years of cardiac monitoring, ECG overread (the expert clinical review of ECG recordings by trained technicians and cardiologists), and regulatory validation ex...
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE...
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
Founding Architect of Canadian Cardiac Electrophysiology and 45-Year Authority on Electrocardiography Joins AIML's Medical Advisory Board TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovatio...
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
Collaboration Expands Reach of MaxYield™ into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "Com...
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 27, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C...
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
Agreement expands NeuralCloud's role in cardiovascular research and academic collaborations MaxYield™ platform to support heart rate variability analysis in post-exertional malaise research TORONTO, O...
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 12, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C...
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
Intelimed Appointed Exclusive Distributor in Chile and Non-Exclusive Distributor Across Latin America to lead commercialization in the region TORONTO, ON / ACCESS Newswire / February 24, 2026 / AI/ML ...
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead ECG ...
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
Engagement Supports Commercial Readiness Strategy for MaxYield™ and CardioYield™ in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company...
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovations I...
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
Collaboration enables integrated device-plus-AI offerings supporting scalable ECG analysis, visualization, and report generation Combination of single-lead wearable devices and AI algorithms creating ...
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable Hol...
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIM...
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Propert...
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
A Look Back at Key Milestones and Successes Achieved in 2025 What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026 Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS News...
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership po...
AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing
Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance markets Pilot ties MaxY...
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance markets Commercial integration expands MaxYield™ and CardioYield™ into ...